Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1994-11-23
|
pubmed:abstractText |
Sarcoidosis is a systemic granulomatous disease of unknown etiology in which CD4+ T cells seem to be critically involved. In the lungs of patients with pulmonary disease, CD4+ T cells accumulate in large numbers, and a subset of these cells is activated. By using both quantitative PCR and anti-V beta mAbs, we analyzed the TCR repertoire of total and activated bronchoalveolar lavage T cells, the latter subset being defined by the ability to proliferate in short-term culture supplemented with IL-2. Overall, there was little difference when TCR V beta expression of freshly isolated lung and peripheral blood cells was compared in individual patients. Some individuals did demonstrate a modest increase in a few V beta-expressing subsets. However, after 1 to 2 wk of in vitro growth in IL-2-supplemented media, bronchoalveolar lavage cells from most patients, but not from any healthy individuals, demonstrated a selective expansion of particular V beta-expressing subsets. Interestingly, different V beta-bearing subsets were expanded in different patients. Junctional region sequencing indicated that the proliferating T cells in culture were strikingly oligoclonal and were derived from T cell clones already selectively expanded in vivo. These results provide evidence for a disease process that involves recognition of local Ag(s) by specific subsets of CD4+ T cells. Analysis of the Ag specificity of these IL-2-expanded populations is likely to provide insight into the pathogenesis of this disease.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
153
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4291-302
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7930629-Adult,
pubmed-meshheading:7930629-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:7930629-CD4-Positive T-Lymphocytes,
pubmed-meshheading:7930629-Clone Cells,
pubmed-meshheading:7930629-Female,
pubmed-meshheading:7930629-Flow Cytometry,
pubmed-meshheading:7930629-Gene Expression,
pubmed-meshheading:7930629-Humans,
pubmed-meshheading:7930629-Interleukin-2,
pubmed-meshheading:7930629-Male,
pubmed-meshheading:7930629-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:7930629-Sarcoidosis, Pulmonary
|
pubmed:year |
1994
|
pubmed:articleTitle |
TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis.
|
pubmed:affiliation |
Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|